Idexx Laboratories (IDXX) EPS (Basic) (2009 - 2026)

Idexx Laboratories (IDXX) has reported EPS (Basic) for 18 consecutive years, with $3.5 the latest figure, recorded in Q1 2026.

• In Q1 2026, EPS (Basic) rose 17.15% year-over-year to $3.5; the TTM figure through Mar 2026 stood at $13.75 (up 24.94% YoY), while the FY2025 annual figure was $13.17, up 22.35% from the prior year.
• EPS (Basic) came in at $3.5 for Q1 2026 at Idexx Laboratories, up from $3.09 in the prior quarter.
• The five-year high for EPS (Basic) was $3.66 in Q2 2025, with the low at $1.57 in Q2 2022.
• Average EPS (Basic) over 5 years is $2.69, with a median of $2.62 recorded in 2024.
• Across the five-year window, EPS (Basic) slumped 33.52% in 2022 and soared 71.61% in 2023, its largest moves.
• Year by year, EPS (Basic) stood at $2.06 in 2022, then gained by 13.72% to $2.34 in 2023, then grew by 11.93% to $2.62 in 2024, then gained by 17.74% to $3.09 in 2025, then increased by 13.29% to $3.5 in 2026.
• According to Business Quant data, EPS (Basic) over the past three periods registered $3.5, $3.09, and $3.43 for Q1 2026, Q4 2025, and Q3 2025 respectively.